JPRN-UMIN000002920已完成2 期
Phase II trial of neoadjuvant chemotherapy with mFOLFOX6 plus Bevacizumab for resectable local recurrent rectal cancer - N-SOG 02
agoya Surgical Oncology Group0 个研究点目标入组 25 人开始时间: 2009年12月21日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 74years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Unresectable local recurrent rectal cancer 2. Active infections 3. With brain metastases 4. Severe neuropathy 5. Pregnant 6. Prebious history of severe drug-induced allergy 7. Serious complications 8. With interstitial lung disease or pulmonary fibrosis 9. Multiple malignancies to be treated 10. Uncontrollable peptic ulcer disease 11. Disqualified by attending doctor
研究者
相似试验
已完成
2 期
Phase II trial of adjuvant chemotherapy with modified medication of S-1 for pancreatic cancerpancreatic cancerJPRN-UMIN000002791Kyoto University Hospital35
招募中
2 期
A phase II trial of neoadjuvant chemotherapy using the combination of gemcitabine and cisplatin for patients with initially unresectable locally advanced biliary tract cancer.Biliary tract cancer (Intrahepatic cholangiocarcinoma, Extrahepatic cholangiocarcinoma, Gallbladder carcinoma)JPRN-UMIN000015330Adjuvant therapy for BTC Research Group50
招募中
2 期
Phase II study of the neoadjuvant chemotherapy of GEM/nab-PTX for biological borderline-resectable pancreatic cancerC535836pancreatic cancerJPRN-jRCT1041230068Ebata Tomoki50
招募中
2 期
Phase II Trial of neoadjuvant chemotherapy with docetaxel, cisplatin and 5-FU for advanced esophageal canceresophageal cancerJPRN-UMIN000007408Second Department of Surgery, Wakayama Medical University40
招募中
不适用
A phase II trial of neoadjuvant chemotherapy with docetaxel,cisplatin and S-1 (DCS) for radically resectable advanced gastric carcinoma (KDOG 1001)radically resectable advanced gastric carcinomaJPRN-UMIN000003642Kitasato University School of Medicine40